Sanofi India has reported results for third quarter ended September 30, 2016.
The company has reported 11.17% rise in its net profit at Rs 80.60 crore for the quarter under review as compared to Rs 72.50 crore for the same quarter in the previous year. Total income of the company increased by 7.36% at Rs 639.00 crore for the quarter under review as compared Rs 595.20 crore for the corresponding quarter previous year.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
